First-in-class macrocyclic peptide therapeutic for rheumatoid arthritis
Ended Project Grant Awarded Last action
- Award ID
- R44AR068833
- Recipient
-
Oryn Therapeutics, Inc. UEI STTZK8ZF37W4
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,495,283
Award facts
- Assistance listing
- 93.846 Arthritis, Musculoskeletal and Skin Diseases Research
- Completion date
- Originally
- Place of performance
- Vacaville, CA 95688, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $352,749 | |
| Original award | $1,142,534 |
Quick answers
Who received award R44AR068833?
R44AR068833 was awarded to Oryn Therapeutics, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on August 7, 2015.
How much is award R44AR068833 worth?
$1,495,283 has been obligated on R44AR068833.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award